Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P134. A change in the attention to patients with inflammatory bowel disease: An integrated care unit
P134. Is faecal calprotectin a useful marker of postoperative recurrence in Crohn's ileal disease?
P134. The impact of wireless capsule endoscopy in suspected Crohn's disease – a longitudinal study
Authors:

B. Hall, G. Holleran, D. Costigan, O. Thornton, M. Dobson, D. McNamara, Department of Clinical Medicine and Gastroenterology, AMNCH & Trinity College, Dublin, Ireland

P134

Clinical, Morphological and Histological Features of X-linked Lymphoproliferative Syndrome Type 2 Enteritis Diagnosed in three Cases with Childhood Onset Inflammatory Bowel Disease

Authors:

T. Ogashiwa*1, R. Kunisaki1, H. Yasuhara1, S. Tsuda1, R. Koh1, K. Yazawa1, K. Goto1, H. Kimura1, A. Sugita2, M. Mori3, M. Tanaka4, H. Kanegane5, S. Maeda6

1Yokohama City University Medical centre, Inflammatory Bowel Disease Centre, Yokohama, Japan, 2Yokohama Municipal Citizen’s Hospital, Department of Inflammatory Bowel Disease, Yokohama, Japan, 3Yokohama City University Medical centre, Department of Pediatrics, Yokohama, Japan, 4Hirosaki City Hospital, Department of Pathology and Laboratory Medicine, Hirosaki, Japan, 5Graduate School of Medicine, University of Toyama, Department of Pediatrics, Toyama, Japan, 6Yokohama City University Graduate School of Medicine, Yokohama, Department of Gastroenterology, Yokohama, Japan

P135. 8-year experience of enterocutaneous fistulae at a national intestinal failure centre
P135.

Sleep disorders in inflammatory bowel disease: incidence and use of ambulatory polysomnography

Authors:

A. Shitrit1, C. Chen Shuali2, B. Koslowsky1, T. Adar1, S. Shteingart1, E. Goldin1, 1Shaare Zedek Medical Center, Digestive diseases institute, Jerusalem, Israel, 2Shaare Zedek Medical Center, Internal Medicine, Jerusalem, Israel

P135. Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, CRP or blood leukocytes
P135. The delay of an acute severe colitis in the course of an inflammatory bowel disease: is it a prognostic factor?
Authors:

N. Ben Mustapha1, A. Laabidi2, H. Dabbabi2, M. Serghini2, L. Kallel2, J. Boubaker2, M. Fekih2, A. Filali2, 1La Rabta Hospital, Gastro A Unit, Tunis, Tunisia, 2La Rabta Hospital, Gastro A Unit, Tunis, Tunisia

P135

Diagnostic delay in IBD- Evaluation of risk factors

Authors:

A. Degen*1, C. Buening2, B. Siegmund3, M. Prager4, J. Maul3, J. Preiss3, B. Wiedenmann1, A. Sturm5, A. Schirbel1

1Charite Campus Virchow Klinikum, Hepatology and Gastroenterology, Berlin, Germany, 2Krankenhaus Waldfriede, Internal Medicine, Berlin, Germany, 3Charite, Hepatology and Gastroenterology Campus Benjamin Franklin, Berlin, Germany, 4Charite Campus Mitte, Gastroenterology, Hepatology & Endocrinology, Berlin, Germany, 5DRK Klinikum Westend, Gastroenterology, Berlin, Germany

P136.

Simple endoscopic score for Crohn's disease (SES-CD) predicts long-term prognosis in Crohn's disease patients with clinical remission

Authors:

M. Naganuma1, N. Inoue2, K. Matsuoka3, T. Hisamatsu3, Y. Iwao2, T. Kanai3, H. Ogata1, 1Keio University, Center for Diagnostic and Therapeutic Endoscopy, Tokyo, Japan, 2Keio University School of Medicine, Center for Preventive Medicine, Tokyo, Japan, 3Keio University, Gastroenterology and Hepatology, Tokyo, Japan

P136. Contrast enhanced abdominal ultrasound in IBD. Comparison with Ileocolonoscopy and MR Enterography
P136. Induction and maintenance of clinical remission by adalimumab in patients with moderate-to-severe ulcerative colitis
P136. The clinical importance of in vitro interferon-gamma assay for differential diagnosis between intestinal tuberculosis and Crohn's disease
Authors:

S.-K. Kim1, Y.-H. Kwon1, 1Kyungpook National University, Gastroenterology, Daegu, South Korea

P136

Usefulness of serum IL-32 and IL-33 as a predictor of clinical course in Crohn's disease

Authors:

E.R. Kim*, Y.K. Park, S.N. Hong, D.K. Chang, Y.-H. Kim

Samsung Medical Center, Internal medicine, Seoul, Korea, Republic of

P137.

Sexual dysfunction in inflammatory bowel disease patients

Authors:

O. Yanartas1, H.T. Kani2, M. Banzragch3, E. Bicakci3, A. Sakalli Kani4, O. Atug3, K. Kuscu1, N. Imeryuz3, H. Akin3, 1Marmara University, School of Medicine, Psychiatry, Istanbul, Turkey, 2Marmara University, School of Medicine, Internal Medicine, Istanbul, Turkey, 3Marmara University, School of Medicine, Gastroenterology, Istanbul, Turkey, 4Istanbul University Cerrahpasa Medical Faculty, Psychiatry, Istanbul, Turkey

P137. Effect of concomitant immunomodulator use on the efficacy of adalimumab in Crohn's disease patients stratified by prior anti-TNF use
P137. Long-term outcome of paediatric-onset Crohn's disease: A population-based study
P137. The usefulness of in vitro interferon-γ assay for differential diagnosis between intestinal tuberculosis and Crohn's disease
Authors:

D.H. Baek1, G.A. Song1, D.Y. Ryu1, D.U. Kim1, 1Pusan national university hospital, Internal medicine, Busan, South Korea

P137

5 year budget impact analysis of CT-P13 (Infliximab) for the treatment of Crohn's Disease in UK, Italy and France

Authors:

J. Kim1, J. An Hong*1, A. Kudrin2

1CELLTRION HEALTHCARE, Medical Communications, Incheon, South Korea, 2CELLTRION, Product development Div. , Incheon, South Korea

P138.

Severe disease activity and cytomegalovirus colitis are associated with an increased risk of venous thromboembolism in patients with inflammatory bowel disease

Authors:

K.-J. Kim, H.-S. Lee, S.H. Park, B.D. Ye, D.-H. Yang, K.W. Jung, J.-S. Byeon, S.-J. Myung, S.-K. Yang, J.-H. Kim, S.-M. Hong, Asan Medical Center, Gastroenterology, Seoul, Korea, Republic of